InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
11
T+90 hit rate
25%
T+90 mean return
-15.1%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Amoroso Michael, Chairman & CEO. Director active across 2 companies, notably Abeona Therapeutics INC.. Cumulatively, 27 reports have been recorded. Split: 0 buy · 11 sells. Total volume traded: €176k. History available since 30 September 2021. The latest transaction was disclosed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations27 total
37,313 shares0Common StockSEC:0001493152-26-003806:0
9,444 shares0Common StockSEC:0001628280-25-048855:0
3,409 shares@ US$6.499.6% of flowCommon StockSEC:0001628280-25-048855:1
3,417 sharesCommon StockSEC:0000950170-25-044599:0
964 shares@ US$5.562.5% of flowCommon StockSEC:0000950170-25-044599:1
36,101 shares0Common StockSEC:0001493152-25-004750:0
115,388 sharesCommon StockSEC:0000950170-25-008013:0
9,443 sharesCommon StockSEC:0000950170-24-121726:0
3,012 shares@ US$8.1911.3% of flowCommon StockSEC:0000950170-24-121726:1
11,797 shares0Common StockSEC:0001493152-24-034052:0
23,611 shares0Common StockSEC:0001493152-24-026645:0
8,334 shares@ US$12.0046.5% of flowCommon StockSEC:0000950170-24-056141:0
3,417 sharesCommon StockSEC:0000950170-24-053112:0
266,720 sharesCommon StockSEC:0001209191-24-002119:0
137,390 shares@ US$0.3622.7% of flowCommon StockSEC:0001209191-24-002119:1
283,390 sharesCommon StockSEC:0001209191-23-054549:0
5,508 shares@ US$3.91115.7% of flowCommon StockSEC:0001493152-23-034855:0
327 shares@ US$3.900.3% of flowCommon StockSEC:0001493152-23-033446:0
338 shares@ US$4.450.4% of flowCommon StockSEC:0001493152-23-021996:0
58,689 shares@ US$4.6269.2% of flowCommon StockSEC:0001493152-23-021653:0
102,535 sharesCommon StockSEC:0001209191-23-020716:0
268 shares@ US$2.330.2% of flowCommon StockSEC:0001493152-23-008429:0
1,002 shares@ US$2.380.6% of flowCommon StockSEC:0001493152-23-006716:0
24,208 sharesCommon StockSEC:0001209191-22-053956:0
11,006 shares@ US$1.327.4% of flowCommon StockSEC:0001209191-22-053956:1
25 of 27 declarations
About Amoroso Michael
Michael Amoroso is the Chief Executive Officer of Abeona Therapeutics Inc. He is responsible for the strategic direction of the company, focusing on the development of innovative therapies. His experience in the biopharmaceutical sector is a valuable asset for Abeona's growth.
